- Home
- PRI vs RGC Comparison
PRI vs RGC Comparison
Compare PRI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRI | RGC |
|---|---|---|
| Founded | 1927 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 11.5B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRI | RGC |
|---|---|---|
| Price | $254.55 | $35.88 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $294.00 | N/A |
| AVG Volume (30 Days) | ★ 158.2K | 105.2K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 67.10 | N/A |
| EPS | ★ 22.91 | N/A |
| Revenue | ★ $3,291,713,000.00 | N/A |
| Revenue This Year | $4.43 | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | $10.91 | ★ N/A |
| Revenue Growth | ★ 6.56 | N/A |
| 52 Week Low | $230.09 | $9.39 |
| 52 Week High | $288.03 | $950.00 |
Technical Indicators
Market Signals| Indicator | PRI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 68.40 |
| Support Level | $246.70 | $12.29 |
| Resistance Level | $255.74 | $36.75 |
| Average True Range (ATR) | 5.41 | 3.45 |
| MACD | 0.55 | 0.86 |
| Stochastic Oscillator | 89.25 | 78.48 |
Price Performance
Historical ComparisonAbout PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.